23rd Annual Forum on

Biotech & Pharmaceutical Patenting

Utilising Successful Strategies to Protect Your Global Biotech & Pharma Patent Portfolio and Maximise Revenues

Wednesday, October 10 to Thursday, October 11, 2012
TBC, London

In a rapidly shifting legal environment for the pharma industry, it has become crucial that biotech companies seek the most practical and competitive strategies for obtaining, extending and protecting their patent portfolios. The 2012 London Biotech & Pharmaceuticals Patenting forum will focus on latest legal developments affecting biotech companies, with a particular focus on successful techniques and strategies for drafting and filing patent applications in multiple jurisdictions. The event will provide a unique opportunity for you to network with your fellow industry peers, key industry regulators and expert patent attorneys from across globe, allowing you to develop your current biotech practices and remain competitive in today’s rapidly changing market.

C5’s 23rd Forum on Biotech & Pharmaceuticals Patenting brings together experienced in-house counsel from both innovator and generic pharma and biotech companies and their expert legal advisors from various jurisdictions across the globe. Based on their personal experience, the expert panel will lead you through invaluable, practical, and in-depth sessions on:

·         The latest case law developments regarding SPCs and the impact on the industry

·         The patentability of diagnostic methods and the implications of the Prometheus case in the US

·         A comparison of the approaches in the EU member states on research exemptions in clinical trials

·         The use of patent litigation insurance cover to enable smaller life science developers to protect their IP

·         The latest strategies and priorities of the EPO

·         A comparison of the approaches to inventiveness in different member states in the EU

·         Procedural developments in Europe, including developments in evidence collection proceedings

·         Analysing the US Biosimilars Framework  and developments in the EU

·         An update on case law in key jurisdictions including the US, UK, Germany, France and Switzerland

 

and much more…

 

  

C5’s Biotech & Pharmaceutical Patenting conference is the ONE place biotech and pharmaceutical patent practitioners come to learn and discuss the most recent and vital changes facing the industry today. Join us for an unparalleled learning and networking opportunity!



The brochure for this event is currently in production.

To ensure you receive a brochure​, please send an email to Toby Hartley requesting a brochure as soon as it becomes available.

Contact: T.Hartley@C5-Online.com